Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11826 | 951 | 21.4 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
11826 | 1 | SULBACTAM//SULTAMICILLIN//AMPICILLIN SULBACTAM | 951 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SULBACTAM | authKW | 349408 | 4% | 27% | 40 |
2 | SULTAMICILLIN | authKW | 288953 | 2% | 60% | 15 |
3 | AMPICILLIN SULBACTAM | authKW | 218668 | 2% | 36% | 19 |
4 | AMOXICILLIN SULBACTAM | authKW | 205483 | 1% | 80% | 8 |
5 | BETA LACTAMASE INHIBITORS | authKW | 156302 | 3% | 17% | 28 |
6 | TAZOBACTAM | authKW | 92029 | 2% | 16% | 18 |
7 | PIPERACILLIN TAZOBACTAM | authKW | 79653 | 2% | 11% | 22 |
8 | BETALACTAMASES INHIBITORS | authKW | 64214 | 0% | 100% | 2 |
9 | BRL 42715 | authKW | 64214 | 0% | 100% | 2 |
10 | CAS 76497 13 7 | authKW | 64214 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 10926 | 32% | 0% | 305 |
2 | Pharmacology & Pharmacy | 8977 | 56% | 0% | 535 |
3 | Microbiology | 8448 | 40% | 0% | 376 |
4 | Medicine, General & Internal | 389 | 11% | 0% | 103 |
5 | Medicine, Research & Experimental | 175 | 6% | 0% | 59 |
6 | Immunology | 107 | 7% | 0% | 66 |
7 | Pathology | 84 | 3% | 0% | 32 |
8 | Veterinary Sciences | 74 | 4% | 0% | 40 |
9 | Toxicology | 59 | 3% | 0% | 30 |
10 | Chemistry, Medicinal | 41 | 3% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THORAC CARDIOVASC HEPATOBILIARY PANCREAT S | 41277 | 0% | 43% | 3 |
2 | ANTIBIOL | 34949 | 1% | 16% | 7 |
3 | A GEMELLI CLIN MICROBIOL | 32107 | 0% | 100% | 1 |
4 | ANTIBIOL BACTERIENNES | 32107 | 0% | 100% | 1 |
5 | BIOL HIRAISHI KAWAUCHI CHO | 32107 | 0% | 100% | 1 |
6 | CHILDRENS EAR NOSE THROAT | 32107 | 0% | 100% | 1 |
7 | DET FARMACOL TER EUT | 32107 | 0% | 100% | 1 |
8 | DONGIAK KU | 32107 | 0% | 100% | 1 |
9 | HUAN SHAN HOSP | 32107 | 0% | 100% | 1 |
10 | I DOGRAMACI CHILDRENS HOSP | 32107 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 40875 | 13% | 1% | 126 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 15799 | 11% | 0% | 108 |
3 | REVIEWS OF INFECTIOUS DISEASES | 8521 | 3% | 1% | 26 |
4 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 6937 | 4% | 1% | 34 |
5 | JOURNAL OF CHEMOTHERAPY | 6248 | 2% | 1% | 22 |
6 | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 6201 | 3% | 1% | 27 |
7 | PATHOLOGIE BIOLOGIE | 4966 | 3% | 1% | 26 |
8 | ANTIBIOTIKI I KHIMIOTERAPIYA | 4420 | 1% | 2% | 9 |
9 | INFECTION | 3742 | 2% | 1% | 21 |
10 | CHEMOTHERAPY | 3634 | 2% | 1% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SULBACTAM | 349408 | 4% | 27% | 40 | Search SULBACTAM | Search SULBACTAM |
2 | SULTAMICILLIN | 288953 | 2% | 60% | 15 | Search SULTAMICILLIN | Search SULTAMICILLIN |
3 | AMPICILLIN SULBACTAM | 218668 | 2% | 36% | 19 | Search AMPICILLIN+SULBACTAM | Search AMPICILLIN+SULBACTAM |
4 | AMOXICILLIN SULBACTAM | 205483 | 1% | 80% | 8 | Search AMOXICILLIN+SULBACTAM | Search AMOXICILLIN+SULBACTAM |
5 | BETA LACTAMASE INHIBITORS | 156302 | 3% | 17% | 28 | Search BETA+LACTAMASE+INHIBITORS | Search BETA+LACTAMASE+INHIBITORS |
6 | TAZOBACTAM | 92029 | 2% | 16% | 18 | Search TAZOBACTAM | Search TAZOBACTAM |
7 | PIPERACILLIN TAZOBACTAM | 79653 | 2% | 11% | 22 | Search PIPERACILLIN+TAZOBACTAM | Search PIPERACILLIN+TAZOBACTAM |
8 | BETALACTAMASES INHIBITORS | 64214 | 0% | 100% | 2 | Search BETALACTAMASES+INHIBITORS | Search BETALACTAMASES+INHIBITORS |
9 | BRL 42715 | 64214 | 0% | 100% | 2 | Search BRL+42715 | Search BRL+42715 |
10 | CAS 76497 13 7 | 64214 | 0% | 100% | 2 | Search CAS+76497+13+7 | Search CAS+76497+13+7 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DAJANI, AS , (2001) USE OF AMPICILLIN/SULBACTAM AND SULTAMICILLIN IN PEDIATRIC INFECTIONS: A RE-EVALUATION.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 29. ISSUE 4. P. 257-269 | 35 | 90% | 7 |
2 | DE LA PENA, A , DERENDORF, H , (1999) PHARMACOKINETIC PROPERTIES OF BETA-LACTAMASE INHIBITORS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 37. ISSUE 2. P. 63-75 | 43 | 70% | 9 |
3 | ITOKAZU, GS , DANZIGER, LH , (1991) AMPICILLIN-SULBACTAM AND TICARCILLIN-CLAVULANIC ACID - A COMPARISON OF THEIR INVITRO ACTIVITY AND REVIEW OF THEIR CLINICAL EFFICACY.PHARMACOTHERAPY. VOL. 11. ISSUE 5. P. 382-414 | 65 | 51% | 13 |
4 | KOZYREV, VN , (1992) CLINICAL ASPECTS OF PHARMACOKINETICS OF UNAZIN (A AMPICILLIN-SULBACTAM COMBINATION).ANTIBIOTIKI I KHIMIOTERAPIYA. VOL. 37. ISSUE 10. P. 46-51 | 31 | 100% | 0 |
5 | ABDEL-RAHMAN, SM , KEARNS, GL , (1998) THE BETA-LACTAMASE INHIBITORS: CLINICAL PHARMACOLOGY AND RATIONAL APPLICATION TO COMBINATION ANTIBIOTIC THERAPY.PEDIATRIC INFECTIOUS DISEASE JOURNAL. VOL. 17. ISSUE 12. P. 1185 -1194 | 35 | 69% | 3 |
6 | TODD, PA , BENFIELD, P , (1990) AMOXICILLIN CLAVULANIC ACID - AN UPDATE OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 39. ISSUE 2. P. 264-307 | 74 | 39% | 104 |
7 | BRUYERE, F , DIHN, A , SOTTO, A , (2016) INTEREST OF AMOXICILLIN-CLAVULANIC ACID COMBINATION IN UROLOGY: AN UPDATE.PROGRES EN UROLOGIE. VOL. 26. ISSUE 8. P. 437 -441 | 15 | 79% | 0 |
8 | SANDERS, WE , SANDERS, CC , (1996) PIPERACILLIN TAZOBACTAM: A CRITICAL REVIEW OF THE EVOLVING CLINICAL LITERATURE.CLINICAL INFECTIOUS DISEASES. VOL. 22. ISSUE 1. P. 107-123 | 31 | 63% | 33 |
9 | BENSON, JM , NAHATA, MC , (1988) SULBACTAM AMPICILLIN, A NEW BETA-LACTAMASE INHIBITOR BETA-LACTAM ANTIBIOTIC COMBINATION.DRUG INTELLIGENCE & CLINICAL PHARMACY. VOL. 22. ISSUE 7-8. P. 534-541 | 38 | 76% | 10 |
10 | BRYSON, HM , BROGDEN, RN , (1994) PIPERACILLIN/TAZOBACTAM - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL.DRUGS. VOL. 47. ISSUE 3. P. 506-535 | 42 | 47% | 56 |
Classes with closest relation at Level 1 |